Sartorius Stedim Biotech S.A. (FRA:56S1)

Sartorius Stedim Biotech Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	699.3	678.9	116.6	107.1	223.6	59.76
Short-Term Investments	3.5	9.9	9.5	24.8	12.7	9.84
Cash & Short-Term Investments	702.8	688.8	126.1	131.9	236.3	69.61
Cash Growth	54.77%	446.23%	-4.40%	-44.18%	239.49%	90.47%
Accounts Receivable	263.8	265.9	293.7	404.6	356	256.89
Other Receivables	39.3	33.8	39.8	14	14.7	6.06
Receivables	303.1	300.6	334.4	419.7	371.7	263.96
Inventory	693.9	684.9	882.4	1,025	783	471.03
Other Current Assets	107.3	66.7	72.2	94.8	64.6	69.34
Total Current Assets	1,807	1,741	1,415	1,671	1,456	873.95
Property, Plant & Equipment	1,954	1,163	1,036	808	640.2	518.6
Long-Term Investments	21.3	24	40.8	24.9	14.8	-
Goodwill	2,889	2,908	2,885	1,136	820.7	725.15
Other Intangible Assets	1,569	1,361	1,465	712.1	563.3	473.83
Long-Term Deferred Tax Assets	69.1	63.2	60	61.6	46.5	27.48
Long-Term Deferred Charges	-	269	227.8	164.2	120.9	98.05
Other Long-Term Assets	3.7	727.6	601	487	289.1	139.68
Total Assets	8,312	8,256	7,730	5,065	3,951	2,857
Accounts Payable	346.9	310	258.5	251.5	251.4	174.73
Accrued Expenses	90.4	88.2	62.3	74.1	97.2	59.9
Current Portion of Long-Term Debt	110.7	39.5	57.7	4.5	25.5	13.11
Current Portion of Leases	22.3	25	21.4	19.5	14.9	10.88
Current Income Taxes Payable	81.6	123.2	189.4	209.6	165	71.52
Current Unearned Revenue	178.1	216.1	238.6	271	259.6	156.76
Other Current Liabilities	116.1	136.8	109.4	205.7	223.5	80.94
Total Current Liabilities	946.1	938.8	937.3	1,036	1,037	567.84
Long-Term Debt	2,684	2,684	3,510	1,021	521.1	515.66
Long-Term Leases	152.1	120.6	93.1	91.1	64	47.46
Long-Term Deferred Tax Liabilities	363.8	358.2	389.4	178.3	125.8	85.08
Other Long-Term Liabilities	93.7	91.3	92.2	189.7	423	130.15
Total Liabilities	4,273	4,233	5,056	2,551	2,218	1,396
Common Stock	19.5	19.5	18.4	18.4	18.4	18.44
Retained Earnings	2,585	2,496	2,391	2,179	1,397	1,209
Comprehensive Income & Other	-25.2	1,471	229	251.9	240.2	210.42
Total Common Equity	4,004	3,987	2,639	2,449	1,656	1,438
Minority Interest	35.8	37.2	35.3	64.9	77.4	22.88
Shareholders' Equity	4,039	4,024	2,674	2,514	1,733	1,461
Total Liabilities & Equity	8,312	8,256	7,730	5,065	3,951	2,857
Total Debt	2,969	2,870	3,682	1,136	625.5	587.11
Net Cash (Debt)	-2,267	-2,181	-3,556	-1,004	-389.2	-517.5
Net Cash Per Share	-23.27	-22.53	-38.58	-10.89	-4.22	-5.61
Filing Date Shares Outstanding	99.28	97.3	92.16	92.16	92.18	92.18
Total Common Shares Outstanding	99.28	97.3	92.16	92.16	92.18	92.18
Working Capital	861	802.2	477.8	635.3	418.5	306.11
Book Value Per Share	40.33	40.97	28.63	26.58	17.96	15.60
Tangible Book Value	-453.6	-282.4	-1,711	600.8	271.9	239.15
Tangible Book Value Per Share	-4.57	-2.90	-18.57	6.52	2.95	2.59
Land	-	803.1	707.8	509.1	426.2	351.65
Machinery	-	796.2	688.5	581.3	469.7	384.92
Order Backlog	-	1,482	1,495	1,844	1,915	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.